ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

FDA Proposes “Clarification” Of Clinical Studies regulations, Including Sanctions, Inspections

August 18, 1978

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000

Senate Gives NCI More Money, Fewer Strings, Orders Grants Paid At Recommended Levels

October 7, 1983

Adding Avastin Did Not Improve Standard Chemotherapy Regimen

April 27, 2012

Ohio Legislature Gives $1 Million To Cancer Control

August 19, 1983

Hellman, Suit Awarded ASTRO’s Gold Medals

October 26, 1990